GLOB.HEALTH CLINICS O.N.
Global Health Clinics Ltd. operates in the cannabis industry. It operates medical clinics, which guide patients through the process of becoming legal users of marijuana. The company was formerly known as Leo Resources Inc. and changed its name to Global Health Clinics Ltd. in August 2018. Global Health Clinics Ltd. was incorporated in 2013 and is headquartered in Vancouver, Canada.
GLOB.HEALTH CLINICS O.N. (L00) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, GLOB.HEALTH CLINICS O.N. (L00) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
GLOB.HEALTH CLINICS O.N. - Net Assets Trend (None–None)
This chart illustrates how GLOB.HEALTH CLINICS O.N.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for GLOB.HEALTH CLINICS O.N. (None–None)
The table below shows the annual net assets of GLOB.HEALTH CLINICS O.N. from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to GLOB.HEALTH CLINICS O.N.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
GLOB.HEALTH CLINICS O.N. Competitors by Market Cap
The table below lists competitors of GLOB.HEALTH CLINICS O.N. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
URANIUM ENERGY - Dusseldorf Stock Exchang
DU:U6Z
|
$115.76K |
|
Waberers
BUD:WABS
|
$115.82K |
|
Enbridge Inc. CUM RED PREF Series B
PINK:EBRGF
|
$115.84K |
|
Fiberpro Inc.
KO:368770
|
$116.09K |
|
J.M. (JMM.SG)
STU:JMM
|
$115.61K |
|
Plasto-Cargal Group Ltd
TA:PLCR
|
$115.45K |
|
ET-P-I
NYSE:ET-P-I
|
$115.21K |
|
Discount Print USA Inc
PINK:DPUI
|
$115.07K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in GLOB.HEALTH CLINICS O.N.'s equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares GLOB.HEALTH CLINICS O.N.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently GLOB.HEALTH CLINICS O.N. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares GLOB.HEALTH CLINICS O.N.'s net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $9,244,379,027
- Average return on equity (ROE) among peers: -92.52%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| GLOB.HEALTH CLINICS O.N. (L00) | €- | N/A | N/A | $115.69K |
| 26U (26U) | $6.75 Million | -514.32% | 1.08x | $248.33K |
| 27N0 (27N0) | $11.56 Million | -0.93% | 0.00x | $4.66K |
| China Resources Pharmaceutical Group Limited (640) | $90.18 Billion | 4.60% | 1.68x | $940.63 Million |
| CIG WIRELESS (6CW) | $27.09 Million | -110.19% | 3.19x | $56.65 Million |
| Solasia Pharma K.K (9SO) | $1.16 Billion | -167.91% | 0.18x | $34.42 Million |
| Apontis Pharma AG (APPH) | $3.46 Million | -34.21% | 7.59x | $11.70 Million |
| Akebia Therapeutics Inc (AX9) | $635.93 Million | -22.58% | 0.57x | $283.56 Million |
| Biofrontera AG (B8FK) | $-12.89 Million | 0.00% | 0.00x | $3.86 Million |
| AVALA RES (CVJ) | $91.87 Million | -27.32% | 0.11x | $113.22K |
| Deciphera Pharmaceuticals Inc (D05) | $341.69 Million | -52.37% | 0.33x | $2.11 Billion |